课题基金 / 基金详情

Biology of Tie2 in sepsis

Biology of Tie2 in sepsis
Tie2 在脓毒症中的生物学
批准号:
9272430
负责人:
Samir M Parikh
金额:
$43.5万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-15 至 2018-01-15
关键词:
ANGPT1 geneAcuteAcute Lung InjuryAcute Renal Failure with Renal Papillary NecrosisAdultAgonistAlpha CellAngiopoietin-2AngiopoietinsAnthrax diseaseAttenuatedBindingBiological MarkersBiologyBlood CirculationBlood VesselsCardiacCardiomyopathiesCardiovascular PhysiologyCell modelCessation of lifeChronicClinicalComplementComplexCritical CareCritical IllnessDataDicer EnzymeDiseaseDominant-Negative MutationEndothelial CellsEndotheliumExtravasationFDA approvedFOXO1A geneFall preventionFunctional disorderFundingFutureGeneticGenetic ModelsGoalsHealthHospitalizationHourHumanHuman GeneticsImmuneImpairmentIncidenceIndividualInfectionInflammationInflammatoryInvestigationKidneyKnowledgeLaboratoriesLaboratory StudyLigandsLungMeasurableMeasurementMediatingMessenger RNAMicroRNAsMolecularMorbidity - disease rateMusMutant Strains MiceOrganOrganismOutcomePathway interactionsPatient riskPatientsPeptidesPharmaceutical PreparationsPhenotypePhosphorylationPhysiologicalPhysiologyPlasmaPopulationPublishingRNARandomized Clinical TrialsReceptor Protein-Tyrosine KinasesRecombinantsRegulationReportingResearchResearch DesignRodentRodent ModelSepsisSeverity of illnessSignal TransductionSimvastatinTIE-2 ReceptorTNF geneTestingTetanus Helper PeptideTetracyclinesTherapeuticTissuesTranslatingUnited Statesadverse outcomebasedesignexperimental studyfallsimprovedinflammatory milieuinsightloss of functionmortalitynovelpathogenpeptidomimeticspreventpublic health relevanceresponseseptictargeted treatmenttooltranscription factorvascular inflammation

项目摘要

项目成果

Samir M Parikh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Tie-2 receptor is highly and specifically expressed in endothelial cells. Its global constitutive activation in mature blood vessels is thought to mediate vascular quiescence. Sepsis is a common and morbid disease whose cardinal manifestations involve the vasculature. RATIONALE: Both the expression and activation of Tie-2 fall in experimental sepsis, creating a "double-hit" to its constitutive signalng. Stimulation of Tie-2 with recombinant Angiopoietin-1 (Angpt-1, its endogenous agonist ligand) or non-Angpt-1 peptide mimetics prevents multi-organ dysfunction and death in murine sepsis. Angpt-2, the context-dependent antagonist of Tie-2, is elevated in the circulation of septic individuals in proportion to the severity of disease, and early measurement of circulating Angpt-2 may predict adverse outcomes in patients with suspected infection. Despite these promising findings, little is understood about the direct local physiological contributions of impaired Tie-2 signaling and even less is known about the regulation of Tie-2 and its ligands in states of inflammation. HYPOTHESIS: We hypothesize that impaired Tie-2 signaling may contribute to the vascular leakage, vascular inflammation, and multi-organ dysfunction that contribute to death in sepsis. AIMS: To test this, we propose 3 aims: (1) using tissue-specific tetracycline-inducible dominant-negative Tie-2 mice to study the acute and chronic consequences of locally impaired Tie-2 signaling; (2) applying cellular and rodent models of inflammation to identify mechanisms through which Tie-2 expression is suppressed; and (3) elucidating a mechanism of inflammatory Angpt-2 induction that may be attenuated by drugs currently being evaluated in critically ill populations. RESEARCH DESIGN: To execute these parallel aims, we have designed cellular mechanistic studies that will complement state-of-the-art mouse genetic models already validated in our laboratory. These tools will provide unprecedented insights into the biology of Tie-2 through gain- and loss-of-function experiments. We have assembled a team of experts in sepsis research, rodent physiology, mouse genetic models, and Tie-2 signaling to assist us.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Circulating mediators of focal segmental glomerulosclerosis: soluble urokinase plasminogen activator receptor in context.
局灶节段性肾小球硬化症的循环介质:背景中的可溶性尿激酶纤溶酶原激活剂受体。
DOI: 10.1053/j.ajkd.2011.09.011
发表时间: 2012
期刊: American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子: --
作者: [Parikh,SamirM]
通讯作者: Parikh,SamirM
Angiopoietins and Tie2 in vascular inflammation.
血管炎的血管蛋白和TIE2在血管炎症中。
DOI: 10.1097/moh.0000000000000361
发表时间: 2017-09
期刊: Current opinion in hematology
影响因子: 3.2
作者: [Parikh SM]
通讯作者: Parikh SM
DOI: 10.1161/atvbaha.111.233189
发表时间: 2011-11
期刊: Arteriosclerosis, thrombosis, and vascular biology
影响因子: --
作者: [David S, Ghosh CC, Mukherjee A, Parikh SM]
通讯作者: Parikh SM
DOI: 10.1016/j.cyto.2012.04.002
发表时间: 2012-11
期刊: CYTOKINE
影响因子: 3.8
作者: [Clajus, Christian, Lukasz, Alexander, David, Sascha, Hertel, Barbara, Lichtinghagen, Ralf, Parikh, Samir M., Simon, Andre, Ismail, Issam, Haller, Hermann, Kuempers, Philipp]
通讯作者: Kuempers, Philipp
Tie2-driven vascular control in critical illness
  • 批准号:
    10705391
  • 项目类别:
  • 资助金额:
    $9.31万
  • 财政年份:
    2018
  • 负责人:
    Samir M Parikh
  • 依托单位:
Tie2-driven vascular control in critical illness
  • 批准号:
    10539770
  • 项目类别:
  • 资助金额:
    $74.52万
  • 财政年份:
    2018
  • 负责人:
    Samir M Parikh
  • 依托单位:
Tie2-driven vascular control in critical illness
  • 批准号:
    10611529
  • 项目类别:
  • 资助金额:
    $81.64万
  • 财政年份:
    2018
  • 负责人:
    Samir M Parikh
  • 依托单位:
Mitochondrial biogenesis in kidney disease
海外基金